Armata Pharmaceuticals (ARMP) Free Cash Flow (2013 - 2026)
Armata Pharmaceuticals (ARMP) reported Free Cash Flow of -$5.8 million for Q1 2026, up 23.88% on a YoY basis from -$4.7 million in Q1 2025, and up 13.1% sequentially from -$6.7 million in Q4 2025.
Armata Pharmaceuticals (ARMP) Free Cash Flow (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals (ARMP) has 14 years of Free Cash Flow data on file, last reported at -$5.8 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 23.88% year-over-year to -$5.8 million; the trailing twelve-month figure through Mar 2026 stood at -$24.5 million (up 32.54% YoY), and the FY2025 full-year result was -$26.3 million, up 33.29% from the prior year.
- Free Cash Flow climbed to -$5.8 million in Q1 2026, from -$6.7 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$3.8 million in Q1 2022 to a low of -$19.6 million in Q1 2023.
- A 5-year average of -$9.5 million and a median of -$9.3 million in 2022 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow tumbled 421.99% in 2023 and jumped 50.67% in 2025, its largest moves.
- Tracing ARMP's Free Cash Flow over 5 years: stood at -$10.0 million in 2022, then dropped by 4.75% to -$10.5 million in 2023, then increased by 25.28% to -$7.8 million in 2024, then rose by 14.32% to -$6.7 million in 2025, then climbed by 13.1% to -$5.8 million in 2026.
- Business Quant data shows ARMP's Free Cash Flow at -$5.8 million in Q1 2026, -$6.7 million in Q4 2025, and -$4.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Armata Pharmaceuticals | 191.29 Mn | 186.49 Mn | - | -5.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.85 Mn |
| Mar 31, 2026 | -5.85 Mn |
| Dec 31, 2025 | -6.73 Mn |
| Dec 31, 2025 | -6.73 Mn |
| Sep 30, 2025 | -4.54 Mn |
| Sep 30, 2025 | -4.54 Mn |
| Jun 30, 2025 | -7.36 Mn |
| Jun 30, 2025 | -7.36 Mn |
| Mar 31, 2025 | -7.68 Mn |
| Mar 31, 2025 | -7.68 Mn |
| Dec 31, 2024 | -7.85 Mn |
| Dec 31, 2024 | -7.85 Mn |
| Sep 30, 2024 | -9.20 Mn |
| Sep 30, 2024 | -9.20 Mn |
| Jun 30, 2024 | -11.54 Mn |
| Jun 30, 2024 | -11.54 Mn |
| Mar 31, 2024 | -10.83 Mn |
| Mar 31, 2024 | -10.83 Mn |
| Dec 31, 2023 | -10.51 Mn |
| Dec 31, 2023 | -10.51 Mn |